Eagle Pharmaceuticals Inc logo

Eagle Pharmaceuticals Inc Investor Relations Material

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. It primarily offers Ryanodex, an intravenous formulation of dantrolene sodium used for treating patients in various malignant hyperthermia crises. The company also develops Bendeka, a once-daily intravenous formulation of bendamustine hydrochloride that is in late-stage development for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin's lymphoma

Latest company events

Ticker symbol



United States of America

About the company


Dig deeper into the Eagle Pharmaceuticals Inc fundamentals on Quartr.

  • Conference calls from all over the world
  • Search for anything across all transcripts
  • Consensus estimates
  • Comprehensive financial data
  • Read the transcripts or scroll the deck
  • Slide decks and earnings reports
App store link
Android play link
Quartr app screenshot